Anil R Shah1. 1. Division of Facial Plastic Surgery, Department of Otolaryngology, University of Chicago, IL, USA. shah@shahfacialplastics.com
Abstract
OBJECTIVE: Review the safety profile and subjective efficacy of intradermal botulinum toxin type A in facial pore size and sebum production. DESIGN: Retrospective analysis of 20 patients. RESULTS: Twenty consecutive patients with a single application of intradermal botulinum toxin type A were examined: Patients (17/20) noted an improvement in sebum production and a decrease in pores size at 1 month after injection. No complications were observed, and 17/20 patients were satisfied with the procedure. CONCLUSION: Preliminary data suggests that intradermal botulinum toxin may play a role in decreasing sebum production. Further quantitive study may be necessary to determine effects of intradermal botulinum toxin on pore size.
OBJECTIVE: Review the safety profile and subjective efficacy of intradermal botulinum toxin type A in facial pore size and sebum production. DESIGN: Retrospective analysis of 20 patients. RESULTS: Twenty consecutive patients with a single application of intradermal botulinum toxin type A were examined: Patients (17/20) noted an improvement in sebum production and a decrease in pores size at 1 month after injection. No complications were observed, and 17/20 patients were satisfied with the procedure. CONCLUSION: Preliminary data suggests that intradermal botulinum toxin may play a role in decreasing sebum production. Further quantitive study may be necessary to determine effects of intradermal botulinum toxin on pore size.
Authors: Je-Young Park; Jeng-Feng Chen; Hosung Choi; Wilson W S Ho; Ni Nyoman Indra Lesthari; Joyce Teng Ee Lim; Ting Song Lim; Stephen Lowe; Beverly Ong-Amoranto; Vasanop Vachiramon; Rungsima Wanitphakdeedecha; Martina Kerscher Journal: J Clin Aesthet Dermatol Date: 2022-06
Authors: Kui Young Park; Hyun Jung Kwon; Jae Min Kim; Guk Jin Jeong; Beom Joon Kim; Seong Jun Seo; Myeong Nam Kim Journal: Ann Dermatol Date: 2018-10-26 Impact factor: 1.444